eHealth Insomnia Intervention for Adult Survivors of Childhood Cancer
Launched by ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Mar 19, 2020
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying an online program designed to help adult survivors of childhood cancer who are struggling with insomnia, which means having trouble sleeping. Many people who survived childhood cancer report having poor sleep, and this can affect their mood, thinking abilities, and overall health. The goal of the study is to see if this internet-based treatment can improve sleep and whether better sleep can also help with memory and cognitive function, as well as overall quality of life.
To participate in this study, individuals need to be between 18 and 65 years old, have significant insomnia, and show some difficulties with cognitive abilities compared to their peers. They also need to have regular internet access and be comfortable reading and speaking English. Participants will be guided through the program and can expect to learn strategies to improve their sleep. It's important to note that certain conditions, such as a history of brain tumors or current severe sleep disorders, may prevent someone from joining the study. Overall, this trial aims to provide valuable insights into how improving sleep can benefit those who have faced childhood cancer.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Enrollment in CCSS
- • Between the ages of 18 and 65 years old
- • Clinically significant insomnia (i.e. score \>15 on the Insomnia Severity Index)
- • Neurocognitive impairment (i.e. score \>84th %ile of sibling normative data in at least one domain on the CCSS-NCQ)
- • Regular access to the internet (at least 2-3 days per week)
- • Ability to read and speak English
- Exclusion Criteria:
- • History of a brain tumor
- • An irregular schedule that would prevent adoption of intervention strategies (i.e. work schedule resulting in usual bedtime earlier than 8 PM or later than 2 AM or arising time earlier than 4 AM or later than 10 AM)
- • Currently pregnant or breast feeding
- • Behavioral treatment for insomnia in the past 12 months
- • Diagnosis of a schizophrenia or psychotic disorder
- • Alcohol or drug abuse in past year
- • Other concurrent sleep disorders, including narcolepsy, obstructive/central sleep apnea, or restless leg syndrome
- • Current treatment or intervention for cognitive impairment (i.e. stimulant medication, transcranial direct current stimulation)
About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is a premier pediatric research institution dedicated to advancing the treatment and understanding of catastrophic diseases in children, particularly cancer and other life-threatening conditions. Renowned for its innovative clinical trials and cutting-edge research, St. Jude integrates patient care with scientific discovery to develop new therapies and improve outcomes for young patients. The hospital is committed to ensuring that no family receives a bill for treatment, travel, housing, or food, fostering a holistic approach to pediatric care. Through collaboration with global research networks, St. Jude aims to share its findings and expertise to enhance treatment options worldwide, making significant strides in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Patients applied
Trial Officials
Tara Brinkman, PhD
Principal Investigator
St. Jude Children's Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials